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By applying metabolic engineering tools and strategies to engineer synthetic enzyme
pathways, the number and diversity of commodity and specialty chemicals that can be
derived directly from renewable feedstocks is rapidly and continually expanding. This
of course includes a number of monomer building-block chemicals that can be used
to produce replacements to many conventional plastic materials. This review aims to
highlight numerous recent and important advancements in the microbial production of
these so-called “biomonomers.” Relative to naturally-occurring renewable bioplastics,
biomonomers offer several important advantages, including improved control over the
final polymer structure and purity, the ability to synthesize non-natural copolymers, and
allowing products to be excreted from cells which ultimately streamlines downstream
recovery and purification. To highlight these features, a handful of biomonomers have
been selected as illustrative examples of recent works, including polyamide monomers,
styrenic vinyls, hydroxyacids, and diols. Where appropriate, examples of their industrial
penetration to date and end-product uses are also highlighted. Novel biomonomers such
as these are ultimately paving the way toward new classes of renewable bioplastics that
possess a broader diversity of properties than ever before possible.
Keywords: bioplastics, biopolymers, monomers, metabolic engineering
INTRODUCTION
At present, nearly all conventional plastics are derived from non-
renewable natural gas and petroleum resources. Global annual
plastics production exceeded 260million tons in 2009, accounting
for roughly 8% of total worldwide oil consumption (Thompson
et al., 2009). By just 2010, the total mark had grown to 265
million tons, with major producers China at 23.5% of total
production, the European Union at 21.5%, and the rest of
Asia contributing another 20% (Plastics Europe, 2011). North
American producers, meanwhile, contributed to nearly 20.5%
of that mark, consuming approximately 331 million barrels of
liquid petroleum gases (LPG) and natural gas liquids (NGL)
and nearly 11 billion ft3 of natural gas as raw materials in
the process (US Energy Information Administration, 2011), in
addition to sizable energy demands. All told, in the US, for
example, plastics production is responsible for about 4.6% of
total consumption of LPG and NGL, 1.5% of total natural gas
consumption, and ∼1% of total electricity usage. In view of
the declining availability of petrochemical feedstocks, the expec-
tation that global plastics production will surpass 297 million
tons by 2015 (Global Industry Analysts, 2012), and rising con-
sumer demand for “greener” products, there is increased interest
to develop alternative plastics from renewable and sustainable
resources.
In contrast to petroleum and natural gas derived plastics,
“bioplastics” are produced from the carbon and energy stored
in renewable biomass feedstocks. As such, bioplastics offer the
promise to reduce dependence on non-renewable oil and natu-
ral gas, and can positively impact the carbon cycle by consuming
atmospheric CO2 (a greenhouse gas) during biomass feedstock
cultivation. As the global demand for bioplastics is predicted to
triple by 2015 to reach >1 million tons per year to represent a
$2.9 billion market (Freedonia Group, 2009), this field is clearly
ripe for opportunity and advancements. Whereas technologies
exist to convert biomass to plastics through either chemocat-
alytic processing or by using microbial biocatalysts, the focus
here will strictly be on the latter. Together with other recent
and complementary reviews (Erickson et al., 2011; Lee et al.,
2011a,b, 2012; Curran and Alper, 2012), this article seeks to illus-
trate how advancements in metabolic and pathway engineering
are leading to the development of novel biocatalysts and, in so
doing, they are also helping to shape the future of the bioplastics
industry.
NATURALLY-OCCURRING BIOPLASTICS
A number of naturally-occurring biopolymers produced by
microorganisms from renewable resources have been found to
be useful as bioplastics. The most notable are polyhydroxyalka-
noates, or PHAs, which have been extensively reviewed over the
years (Braunegg et al., 1998; Chen, 2009; Keshavarz and Roy,
2010). PHAs are biodegradable, linear polyesters composed pri-
marily of monomer subunits of (R)-3-hydroxybutyrate (3HB)
and are produced as carbon and energy storage molecules by
numerous different microbes from both simple and complex
biomass feedstocks (note that monomers of 3HB and other β-
hydroxyacids will be discussed in detail below). Well-studied
examples of bacterial PHA producers include species of Ralstonia
(Reinecke and Steinbuchel, 2009), Bacillus (Singh et al., 2009),
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and Pseudomonas (Rojas-Rosas et al., 2007), as well as pho-
totrophic cyanobacteria (Asada et al., 1999).
Although PHAs are efficiently produced by microbes via natu-
rally evolved biosynthesis routes, expressing the requisite pathway
enzymes from various natural producers has also enabled their
production at high levels in recombinant Escherichia coli, a more
tractable host platform (Schubert et al., 1988). All told, bacteria
have been engineered to achieve PHA biosynthesis at up to 80%
of cell dry weight and at productivities as high as 4 g/L-h from
substrates such as glucose (Lee et al., 1999). As crystalline and
heat resistant polymers, with glass transition andmelting temper-
atures of around 5◦C and 175◦C, respectively, PHAs are most well
poised as replacements to polyethylene (PE) and polypropylene
(PP) (Pei et al., 2011). However, unlike PE and PP, the natural
biodegradability PHAs ensures that they will not leave a legacy
in landfills at their end of use. Commercial interest in PHAs has
been growing, with Metabolix (Cambridge, MA), for example,
pursuing their large scale development through their Mirel™ and
Mvera™ brands, which collectively are expected to have applica-
tions in the production of fibers, films, and coatings, as well as for
molded and extruded products.
In spite of numerous advantages, PHA production also suf-
fers from other inherent shortcomings which may ultimately
impede their long-term and wide-spread utility. For instance,
while their biodegradable nature can help reduce municipal
waste, this attribute renders PHAs unsuitable for use in appli-
cations requiring long term durability and/or environmental
exposure. As all PHAs are thermoplastic polyesters the achievable
range of physicochemical andmaterial properties, though diverse,
is inherently limited. PHA chain length and purity are difficult to
tune and control with high quality assurance in an in vivo setting.
Lastly, as they are macromolecules, PHAs do not readily diffuse
out from cells, but rather accumulate intracellularly as cytosolic
inclusion bodies. Thus, since PHAs can only be harvested after
the microbial biocatalyst is lysed, prospects for the continuous
bioprocessing of PHAs remain unviable.
Another import class of bioplastics that microorganisms nat-
urally produce are those that can be derived from sugars. For
example, select strains of Acetobacter, most notably A. xylinum,
are capable of producing high quality cellulose by polymeriz-
ing linear chains of β-1,4-glucan (Krystynowicz et al., 2002).
Natural cellulose polymers are most attractive due to their inher-
ent biodegradability. Today,most high-grade cellulose is extracted
from agricultural sources, for example, fast growing trees or cot-
ton linters. Bacterial cellulose is an attractive alternative, however,
because it is free of lignin and hemicelluloses and, with a molec-
ular weight 100-fold lower than plant cellulose, it also possesses
greater mechanical strength (Czaja et al., 2006). After synthesiz-
ing linear β-1,4-glucan chains and secreting them through pores
in their outer membrane, their assembly into microfibril bundles
then takes place outside the cell (Ross et al., 1991). Thus, in con-
trast to PHAs, bacterial cellulose is more amenable to downstream
recovery and purification; however, just as PHAs, it still suffers
from the same quality assurance and quality control concerns.
Nevertheless, bacterial cellulose has found many successful com-
mercial applications. For example, bacterial cellulose is used in
Brazil by BioFill Produtos Biotecnologicos in their line of medical
films (Biofill®, Bioprocess®, and Gengiflex®) (Hoenich, 2006),
whereas Xylos Corp. (Langhorne, PA) also uses it to produce a
line of wound care products (XCell®) (Czaja et al., 2006).
NATURALLY-OCCURRING BIOMONOMERS
Limitations associated with naturally-occurring bioplastics have
motivated a recent shift in focus to the alternative produc-
tion of “biomonomers.” Biomonomers are small molecules (i.e.,
monomeric subunits) that can undergo ex situ chemocatalytic
polymerization to produce plastics. This strategy offers several
distinct advantages. First, since most biomonomers are often nat-
urally excreted from microorganisms the need for cell collection
and lysis is eliminated, greatly reducing operating expenditures
and facilitating downstream product recovery. Polymerization of
biomonomers in highly controlled chemocatalytic environments
leads to bioplastics with finely tuned and predictable proper-
ties and at high purities to satisfy quality control specifications.
Lastly, the ability to co-polymerize biomonomers with other
desired monomers (biologically or otherwise derived) increases
the diversity of plastics that can be produced from renewable
resources, widening the range of achievable chemistries andmate-
rial properties.
In general, there are two classes of biomonomers of industrial
interest. The first can be produced from natural metabolites with
the aid of a few simple catalytic post-processing steps. For exam-
ple, the natural fermentation product ethanol can undergo dehy-
dration to ethylene over a solid acid catalyst (Takahara et al., 2005;
Hu et al., 2010), before later being polymerized to poly(ethylene)
or its co-polymers. Braskem is taking this approach to con-
vert sugarcane-derived ethanol to bioplastics in Brazil (Phillips,
2008). The second class of biomonomers, which will be the
central focus of this review, are those metabolites that them-
selves are directly suitable for polymerization into bioplastics.
Wherever possible, the microbial production of “drop in com-
patible” biomonomers by this approach is advantageous because,
as illustrated in Figure 1, it ensures a seamless interface between
emerging biotechnologies and the existing polymer industry. This
strategy enables decades of technological expertise and existing
process infrastructure to be efficiently leveraged, and effectively
FIGURE 1 | The alternative production of “drop in compatible”
monomer compounds from biomass feedstocks enables the
development of new classes of bio-derived polymers by coupling
emerging biotechnologies with mature polymer processing
technologies.
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allows conventional chemical and plastics processing to “pick up
where biology leaves off.”
The most prominent example of a naturally-occurring
biomonomer is perhaps L(+)-lactic acid, whose polymerization
leads to the polyester poly(lactic acid), or PLA. L(+)-Lactic acid
is a natural fermentation product of numerous microbes, of
which prominent examples include lactic acid bacteria (includ-
ing numerous Lactobacilli sp.) and filamentous fungi (Kosakai
et al., 1997; Zhou et al., 1999). As microbial lactic acid produc-
tion has been extensively reviewed in the past (Wee et al., 2006;
Reddy et al., 2008), it will not be addressed in detail here. It
is worth noting, however, that E. coli been engineered to over-
produce both L(+)- (Zhou et al., 1999) and D(−)- (Zhou et al.,
2003; Mazumdar et al., 2010) stereroisomers of lactic acid as
optically pure products. This is important because lactic acid
stereochemistry greatly controls relevant physical properties of
PLA including, for example, crystallinity and in turn melting
point (Lunt, 1998; Sodergard and Stolt, 2002). In a related and
interesting study, Lee and coworkers recently engineered E. coli for
the direct in vivo production of PLA by modifying the substrate
specificity of PHA synthase 1 of a Pseudomonas sp. and promoting
the production of lactyl-CoA, the monomer precursor, by intro-
ducing an evolved propionate CoA-transferase from Clostridium
propionicum (Jung et al., 2010; Yang et al., 2010). However, just
as PHA is confined within cells, so too is in vivo produced PLA.
Thus, it is not yet clear how easily or well this specific approach
will translate to the commercial scale. Today, NatureWorks LLC
(Minnetonka, MN) already produces > 20 different grades of
their Ingeo™ PLA bioplastics with structures that range from
amorphous to crystalline and uses spanning from films to foams.
Like PHAs, PLA continues to be a desirable target due in large
part to its biodegradability.
A second naturally-occurring biomonomer that has been
extensively investigated to date is succinic acid. This 4-carbon
diacid is a natural fermentation product of numerous bacte-
ria, including Actinobacillus succinogenes, Anaerobiospirillum suc-
ciniciproducens, and Mannheimia succiniciproducens, which have
been reviewed elsewhere (Song and Lee, 2006). Moreover, E. coli’s
metabolism has again also been extensively engineered to over-
produce this minor fermentation product to near theoretical
yields (Thakker et al., 2012). Succinic acid is particularly use-
ful for producing both polyesters and polyamides, and the first
commercial bioplastics derived from this biomonomer will likely
be polyamide-5,4 (Qian et al., 2009) and/or poly(butylene-co-
succinate) (PBS) (Bechthold et al., 2008), a biodegradable ther-
moplastic suitable for extrusion, injection molding, thermoform-
ing, and film blowing (Xu and Guo, 2010). As microbial succinic
acid production is now becoming a mature technology, several
producers, including both Myriant (Quincy, MA) and BioAmber
(Plymouth,MN), are now developing commercial scale fermenta-
tion processes. BioAmber, for example, currently operates a 3000
ton capacity plant in France, with plans to commission a 17,000
ton facility in Canada in 2013.
ENGINEERING NOVEL BIOMONOMERS
Despite the potential advantages of using biomonomers
to produce renewable plastics, a limited pool of useful
naturally-occurring metabolites ultimately constricts the
diversity of bioplastics that can be produced by this approach.
However, by applying metabolic engineering tools and strategies,
de novo metabolic pathway engineering provides the potential to
produce non-natural biomonomers, and novel bioplastics, that
were never before possible.
Through the rational re-engineering of microbial metabolism
“microbial chemical factories” can be constructed to convert
biomass feedstocks into chemical products of high value and/or
utility as greener and more sustainable alternatives to petrochem-
icals (Carothers et al., 2009; Martin et al., 2009). This approach
has already led to significant and recent improvements to the
production of renewable fuels (Atsumi et al., 2008; Atsumi and
Liao, 2008; Peralta-Yahya and Keasling, 2010; Schirmer et al.,
2010; Steen et al., 2010; Mendez-Perez et al., 2011; Rude et al.,
2011), chemicals (Wierckx et al., 2005; Qian et al., 2009; Kind
et al., 2010a; Schirmer et al., 2010; Whited et al., 2010), and
active pharmaceutical ingredients (Ro et al., 2006; Leonard et al.,
2009; Tsuruta et al., 2009; Campbell and Vederas, 2010). As illus-
trated by several examples in Figure 2, these strategies now offer
the same potential to enhance production of novel biomonomers
and, as the following selected examples will illustrate, significant
progress is already being made in this regard.
POLYAMIDE BIOMONOMERS
Polyamides (PAs; also known as nylons) are a class of plastics that
balance mechanical strength and durability with chemical resis-
tance, and which find extensive use as textiles and mechanical
parts. PAs are formed either as homopolymers of amino acids
or as co-polymers via condensation of diamines with diacids.
The most common commercial PAs are PA-6 (a homopolymer
of 6-aminohexanoic acid) and PA-6,6 (a copolymer of adipic acid
and 1,6-hexanediamine) which account for more than 85–90% of
the global market, which will approach 6.6 million tons by 2015
(Nexant Chem Systems, 2009). As carbon chain length between
amide bonds (typically 2–12) strongly influences material prop-
erties, a large diversity of PAs can be generated from a limited
monomer pool by a combinatorial approach. Here, however, we
specifically focus on recent progress and opportunities related to
the microbial production of 4- through 6-carbon linear diamines,
amino acids, and diacids (Figure 3).
Putrescine, the 4-carbon diamine counterpart to succinic
acid, occurs as an amino acid biodegradation product, how-
ever no natural over-producers have been isolated to date.
Putrescine can be produced by E. coli by two different path-
ways that stem from either L-arginine (through agmatine by
SpeAB) or L-ornithine (from L-glutamate by SpeC and SpeF)
(Tabor and Tabor, 1985; Igarashi and Kashiwagi, 2000). Several
researchers have taken to rationally engineering putrescine over-
producing microbes including Qian et al. who, for example,
developed a putrescine over-producing E. coli strain by increas-
ing metabolite flux toward L-ornithine (Qian et al., 2009). This
was achieved through both promoter replacements and targeted
deletions to overcome allosteric and transcriptional regulation
of the L-ornithine biosynthesis pathway. Transcriptional repres-
sion by L-arginine upon the native promoters PargCBH , PargD,
and PargE was alleviated by their replacement with the strong
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FIGURE 2 | Numerous biomonomers can now be produced as a
result of metabolic and pathway engineering; examples discussed
in this review are depicted here. “Boxed” names signify molecules
that have been produced directly from renewable resources, whereas
others have been produced via a hybrid, biocatalytic-chemocatalytic
approach.
promoter Ptrc. Meanwhile, PspeC and PsepFpotE were also replaced
with Ptrc to relieve feed-back regulation by putrescine and to
increase putrescine export through the potE exporter, respectively.
Multiple competing pathways were deleted and the resultant
E. coli strain produced 24.2 g/L putrescine from glucose in fed-
batch cultures (Qian et al., 2009). Corynebacterium glutamicum
has also been used for engineering putrescine over-production
by both the L-ornithine and L-arginine pathways, however, the
L-arginine pathway was ∼40-fold less effective, most likely due
to the inhibitory effects of the urea byproduct (Schneider and
Wendisch, 2010). With the L-ornithine pathway, expression of
L-ornithine decarboxylase from E. coli resulted in putrescine titers
of up to 6 g/L (Schneider and Wendisch, 2010). Thus, the relative
utility of the L-ornithine-derived pathway is conserved between
both host platforms investigated. DSM Engineering Plastics
(The Netherlands) currently uses putrescine derived from cas-
tor oil to produce PA-4,6 and PA-4,10, marketed as Stanyl™ and
EcoPaXX™, respectively. Microbial putrescine production from
simple sugars, however, would add economic and sustainability
benefits.
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FIGURE 3 | Examples of polyamides (PAs) produced from combinations of C4–C6 diamines, diacids, and amino acids. To date, molecules with names
underlined have been produced microbially from renewable resources with the aid of metabolic engineering.
Similar to putrescine, the 5-carbon diamine cadaverine also
naturally occurs as an amino acid decarboxylation product, and
only at low levels. In this case, it is the decarboxylation of L-
lysine that forms cadaverine. PAs derived from cadaverine possess
such desirable properties as high melting points and low water
absorption (Kind and Wittmann, 2011). In addition, PA-5,4 and
PA-5,10 have been proposed as bio-based alternatives to several
petroleum-derived PAs (Kind and Wittmann, 2011; Qian et al.,
2011). Mimitsuka et al. were first to engineer a microbe for
cadaverine over-production from glucose by inserting the acid
inducible lysine decarboxylase (encoded by cadA) of E. coli into
the genome of a L-lysine over-producing strain of C. glutam-
icum, as seen in Figure 4 (Mimitsuka et al., 2007). The same basic
strategy has since been implemented in both E. coli and C. glu-
tamicum which, through additional engineering, have produced
cadaverine up to 9.6 g/L in E. coli and over 10 g/L in C. glutam-
icum on renewable substrates (Mimitsuka et al., 2007; Tateno
et al., 2009; Kind et al., 2010a; Qian et al., 2011). For example,
to further enhance production in E. coli, Qian et al. subsequently
deleted the native enzymes spermacetyl transferase, spermidine
synthase, cadaverine oxidase, and putrescine aminotransferase
(encoded by speG, speE, ygjG, and puuA, respectively) which use
cadaverine as substrate (Qian et al., 2011). In C. glutamicum,
Kind et al. recently showed ldcC of E. coli functions better than
cadA as a result of differences in pH optima (Kind et al., 2010a),
and codon-optimization further aided its function. To increase
the availability of L-lysine, lysE was deleted to eliminate losses
due to lysine export from C. glutamicum (Figure 4) (Kind et al.,
2010b). Genome-wide transcript analysis identified a putative
permease (encoded by cg2893) that was up-regulated in the pres-
ence of cadaverine. While deletion of cg2893 reduced cadaverine
production by 90%, its over-expression using the strong pro-
moter Psod improved cadaverine yields by 20% (Kind et al., 2011).
These results show that if cadaverine can be effectively exported
from cells, the negative impacts of allosteric product feed-back
inhibition on engineered pathways can be reduced. Most impor-
tantly, strategies analogous to those developed here may be of
broader utility to the production of other biomonomers and
biochemicals.
PA homopolymers are produced from amino acid monomers,
a 4-carbon example of which is 4- or γ-aminobutyrate (GABA).
GABA is naturally produced by many organisms from L-
glutamate via glutamate decarboxylase. Whereas a microbe that
produces GABA directly from glucose has yet to be reported,
GABA production from exogenously fed L-glutamate has been
investigated in strains engineered to over-express heterologous
glutamate decarboxylase. For example, up to 5.5 g/L GABA was
produced from 10 g/L of glutamate by E. coli expressing gluta-
mate decarboxylase (encoded by gadB) and the GABA/Glutamate
antiporter (encoded by gadC) (Le Vo et al., 2012). Additionally,
the GABA aminotransferase (encoded by gabT) was deleted to
prevent endogenous GABA degradation. Future engineering of L-
glutamate over-producing hosts will no doubt lead to strains that
can achieve high-level GABA production directly from glucose.
www.frontiersin.org August 2012 | Volume 3 | Article 313 | 5
Adkins et al. Renewable “biomonomers”
FIGURE 4 | Engineering cadaverine production in Corynebacterium glutamicum by (1) over-expressing L-lysine decarboxylase (cadA), (2) disrupting
L-lysine the exporter (lysE ), and (3) over-expressing an identified cadaverine exporter (cg2893).
As illustrated in Figure 3, the bio-production of several other
useful PA monomers has yet to be realized. Like cadaverine, the
5-carbon diacid glutaric acid is known to be a natural L-lysine
degradation product. Numerous Pseudomonas sp., for example,
are known to degrade L-lysine through glutaric acid via 5-
aminovaleric acid (AMV) in the AMV pathway (Revelles et al.,
2007). Thus, if the AMV pathway can be functionally recon-
structed in a L-lysine over-producing host, renewable routes to
PA-5 and PA-5,5 would be possible .While PA-5 has not achieved
commercial realization, it is known to possess properties close to
PA-4,6 and could serve as a suitable substitute (Bermudez et al.,
2000). Meanwhile, the microbial production of three of the most
important conventional PAmonomers, namely 6-aminohexanoic
acid (precursor to PA-6), adipic acid, and 1,6-hexanediamine
(both precursors to PA-6,6) has yet to be demonstrated. The
closest demonstration was of adipic acid production, from Niu
et al. who engineered E. coli to produce cis,cis-muconic acid from
glucose at final concentrations of 36 g/L (Niu et al., 2002). cis,cis-
Muconic acid can be hydrogenated over a palladium catalyst at
high pressures to yield adipic acid. Certainly, however, a “one pot”
biosynthetic approach would be preferred.
STYRENIC VINYLS
Styrenic vinyls are a family of polymers and co-polymers that use
styrene or substituted styrene as a key monomer building-block.
Today, nearly 60% of styrene’s global annual production (about
six million tons in the US manufacturers and 24 million tons
globally), for example, supports plastics production (Sri, 2010).
Examples include polystyrene (PS), acrylonitrile-butadiene-
styrene (ABS), styrene-acrylonitrile (SAN), and styrene buta-
diene rubber (SBR). Low density PS foams, for instance, are
widely used in packaging and as thermal insulators (Thorball,
1967), while the “rubbery” characteristics of SBR make it a nat-
ural rubber alternative and the major constituent of tires and
many gaskets. Today, all styrenic plastics are produced using
petroleum-derived monomers. For example, styrene is produced
via ethylbenzene dehydrogenation (Wu et al., 1981). This reac-
tion, however, demands over 3 metric tons of steam per ton of
styrene produced, rendering styrene as one of the most energy-
intensive commodity petrochemicals (US Department of Energy,
2002). The recent engineering of novel enzymatic routes to both
p-hydroxystyrene (pHS) and styrene and from glucose (Figure 5),
however, may soon enable their renewable production.
The first styrenic biomonomer to be synthesized from renew-
able resources was pHS (Qi et al., 2007). Its innate optical prop-
erties make pHS useful for producing photoresist polymers used
in semiconductor manufacturing, for example (Pawlowski et al.,
1991). As seen in Figure 5, the engineered pHS biosynthesis path-
way stemmed from L-tyrosine as its immediate endogenous pre-
cursor. Only two enzymatic steps were then required to convert
L-tyrosine to pHS. First, the bi-functional phenylalanine/tyrosine
ammonia lyase (PAL/TAL) of the yeast Rhodotorula glutinis cat-
alyzed p-coumaric acid formation. Then, p-coumaric acid was
subsequently decarboxylated by phenylacrylate decarboxylase of
either Bacillus subtilis (encoded by pdc) or Lactobacillus plan-
tarum (encoded by padC). Initial E. coli strains expressing the
pHS pathway achieved final titers as high as only 400mg/L.
Accumulation beyond this mark was severely limited as a result
of pHS toxicity imposed on the E. coli host (Qi et al., 2007). To
overcome toxicity limitations, the well-known aromatic-tolerant
Pseudomonas putida S12 was next investigated as a pHS pro-
duction platform. Utilizing two strains derived from P. putida
S12 to overproduce precursor L-tyrosine as hosts, the pHS path-
way was introduced. Due to the innate ability of P. putida
S12 to degrade numerous aromatic solvents, multiple com-
peting pathway genes were also targeted for deletion. These
included both smo, which encodes styrene monooxygenase, and
fcs, the first gene in the p-coumaric acid degradation pathway.
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FIGURE 5 | Novel pathways engineered for the production of
p-hydroxystyrene and styrene from renewable glucose via aromatic
amino acid precursors.
All told, engineered P. putida S12 strains were able to reach
and tolerate pHS titers as high as 545mg/L, nearly a 50%
improvement.
More recently, our own group engineered a novel path-
way to enable E. coli to produce styrene directly from glucose
(McKenna and Nielsen, 2011). The styrene biosynthetic path-
way is analogous to the pHS pathway (Figure 5), except in
that it stems from L-phenylalanine as its endogenous precur-
sor and as such requires different pathway enzyme “parts.” In
this case, L-phenylalanine ammonia lyase (PAL) first converts
L-phenylalanine to trans-cinnamic acid which is then decarboxy-
lated to styrene. Upon screening numerous enzyme candidates,
it was ultimately found that PAL2 from Arabidopsis thaliana
and FDC1 from Saccharomyces cerevisiae were most effective for
these steps, respectively. By over-expressing PAL2 and FDC1 in
a L-phenylalanine over-producing E. coli host, styrene titers as
high as 264mg/L were achieved. As with pHS, styrene titers too
approached E. coli’s toxicity limit (∼300mg/L) and must simi-
larly be overcome if economical styrene biomonomer production
is to be achieved.
HYDROXYACIDS
In recent years, much attention has been given to the biopro-
duction of the enantiomerically pure hydroxyacids. Not only
is this class of molecules useful as precursors for the pro-
duction of pharmaceuticals, vitamins, antibiotics, and flavor
compounds (Tseng et al., 2009), but hydroxyacids can also
serve as biomonomers to derive other renewable polyesters.
Hydroxyacids of interest in bioplastics include terminal hydrox-
yacids such as 3-hydroxypropionate (3HP), as well as the β-
hydroxyacids 3-hydroxybutyrate (3HB) and 3-hydroxyvalerate
(3HV). Each of these hydroxyacid monomers have been
produced microbially from renewable resources via pathway
engineering.
The shortest of the hydroxyacid monomers is 3HP. 3HP was
previously named one of the 12 “Top Value Added Chemicals
from Biomass” by the US Department of Energy (2004). In addi-
tion to serving as polyester monomer, 3HP can also be used
to produce several other specialty and commodity chemicals
through additional chemocatalytic processing (Rathnasingh et al.,
2009), including the conventional monomers acrylamide, propi-
olactone, malonic acid, and 1,3-propanediol. The most notable
of which, however, is acrylic acid produced by the dehydration
of 3HP. Acrylic acid and its esters are used in polymeric floccu-
lants, dispersants, coatings, paints, and adhesives (Straathof et al.,
2005) and represent a $10 billion global market. Several com-
panies are now pursuing the commercial development of 3HP-
derived acrylic acid, including, for example, OPX Biotechnologies
(Boulder, CO).
While several distinct enzymatic routes have been proposed
for microbial 3HP production (Jiang et al., 2009), two have
demonstrated the greatest promise to date. The first was a two-
step pathway consisting of an adenosylcobalamin dependent
glycerol dehydratase to catalyze the dehydration of glycerol to
3-hydroxypropionaldehyde (3HPA), and an aldehyde dehydro-
genase to oxidize 3HPA to 3HP (Suthers and Cameron, 2000).
Using this pathway, Rathnasingh and coworkers engineered E. coli
to produce 38.7 g/L 3HP in a fed-batch bioreactor with glyc-
erol as substrate. In their strain, glycerol dehydratase (DhaB)
from Klebsiella pneumoniae DSM 2026 and α-ketoglutaric semi-
aldehyde dehydrogenase (KGSADH) from Azospirillum brasilense
were selected (Rathnasingh et al., 2009). A key shortcoming of
this approach, however, was the uneconomical requirement for
exogenous coenzyme-B12 supplementation. To address this limi-
tation, E. coli was later engineered to produce 3HP from glucose
in a coenzyme-B12-independent manner. This second 3HP path-
way consisted of over-expressing the acetyl-CoA carboxylase and
biotinilase genes of E. coli K-12 (accADBCb) to convert endoge-
nously produced acetyl-CoA to malonyl-CoA, and expressing
the NADPH-dependent malonyl-CoA reductase gene (mcr) of
Chloroflexus aurantiacus DSM 635 to reduce malonyl-CoA to
3HP (Rathnasingh et al., 2012). This second pathway, however,
initially suffered from inherent NADPH limitations under aer-
obic conditions. This was ultimately addressed by co-expressing
nicotinamide nucleotide transhydrogenase (pntAB from E. coli)
to convert NADH (the more abundant reducing equivalent) to
NADPH, leading to 3HP titers of up to 0.19 g/L (Rathnasingh
et al., 2012).
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Although both 3HP pathways possess their own unique lim-
itations which hinder their industrial potential, these pathways
represent platforms to which subsequent improvements can now
be made via continued strain development. For example, the B12-
dependent pathway from glycerol may be well-suited for use in
natural organisms which are employed for the industrial produc-
tion of coenzyme-B12, such as Propionibacterium shermanii or
Pseudomonas denitrificans, for example (Martens et al., 2002).
Microbial production of (R)-3HB by recombinant E. coli
was first reported by Gao et al. Their engineered pathway
was composed of phaA and phaB from Ralstonia eutropha (a
natural PHB producer), encoding β-ketothiolase and an (R)-
specific 3-hydroxybutyryl-CoA (R-3HB-CoA) dehydrogenase,
respectively, to convert endogenous acetyl-CoA to 3-HB-CoA
through acetoacetyl-CoA (Figure 6). The ptb-buk operon from
Clostridium acetobutylicum was lastly co-expressed to convert R-
3-HB-CoA to R-3HB (via R-3-hydroxybutyryl phosphate), and
shake flask titers exceeding 2 g/L resulted (Gao et al., 2002). Tseng
et al. later built upon these works, adding the ability to pro-
duce both (R)- and (S)-3HB isomers with high stereoselectivity
and increasing product titers (Tseng et al., 2009). Stereoselective
control was achieved by utilizing two different enantioselective
3HB-CoA dehydrogenases: (R)-selective PhaB from R. eutropha
and (S)-selective Hbd from Clostridium acetobutylicum. It was
also demonstrated that the broad-substrate thioesterase II of
E. coli (encoded by tesB) effectively converted both (R)- and
(S)-3HB-CoA to their respective 3HB isomer products, whereas
ptb-buk was (R)-specific (Tseng et al., 2009). In the end, (R)-
and (S)-3HB titers as high as 2.92 and 2.08 g/L, respectively, were
attained. (R)-3HB biomonomer, can be used to make biodegrad-
able PHB with well-controlled properties. (S)-3HB biomonomer,
meanwhile, can be used to produce novel PHBs with new features
and properties.
Prather and coworkers subsequently expanded upon their
efforts to produce, for the first time, enantiomerically pure
stereoisomers of the 5-carbon β-hydroxyacid 3HV (Tseng et al.,
2010). This was achieved using a single renewable substrate
(glucose) by first engineering E. coli to over-produce precur-
sor propionyl-CoA via manipulation of the native L-threonine
biosynthesis pathway. Propionyl-CoA was condensed with acetyl-
CoA via a thiolase displaying broad substrate specificity (BktB
of R. eutropha). The intermediate product, 3-ketovaleryl-CoA,
is the 5-carbon analog to acetoacetyl-CoA in the 3HB pathway
(Figure 6). Two analogous steps were then used for its stereose-
lective reduction to (R)- or (S)-3HV-CoA and conversion to the
respective hydroxyacids. The use of BktB was essential in demon-
strating the ability of biomonomer chain elongation at the initial
condensation step. One disadvantage to their approach, however,
FIGURE 6 | Pathways engineered for stereoselective production of (R)- and (S)-3-hydroxybutyrate and (R)- and (S)-3-hydroxyvalerate from glucose.
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resulted from the promiscuity of BktB, which led to the simul-
taneous production of acetoacetyl-CoA, and hence 3HB. This
realization implies that control over product purity had dimin-
ished. Nevertheless, in glucose fed cultures, titers of 0.50 and
0.31 g/L of (R)- and (S)-3HV, respectively, were demonstrated.
The subsequent discovery that NADP(H) limitations of PhaB
reduced conversion to (R)-3HV was later overcome using glyc-
erol as substrate, which improved final titers to as high as 0.96 g/L.
Whereas 3HV production has yet be commercially explored, as
a biomonomer it offers the potential develop bioplastics with
broader ranges of properties.
DIOLS
Short-chain diols suitable for bioplastics applications have been
produced microbially via both natural and engineered pathways.
For example, the four-carbon diol 2,3-butanediol (2,3-BDO) is a
natural fermentation product of many microbes, including many
species of Klebsiella, Bacillus, and lactic acid bacteria (Voloch
et al., 1985). Microbial production of 2,3-BDO by both natu-
ral and engineered strains will not be discussed here, however,
as it has been extensively reviewed over the years (Garg and
Jain, 1995; Celinska and Grajek, 2009; Ji et al., 2010; Nielsen
et al., 2010; Ji et al., 2011). Today, companies including LanzaTech
(New Zealand) are developing 2,3-BDO as a biomonomer plat-
form following its chemocatalytic conversion to butadiene. More
recent efforts have focused on engineering microbes to pro-
duce the three-carbon diol 1,3-propanediol (1,3-PDO) and the
four-carbon diol 1,4-butanediol (1,4-BDO). Both 1,3-PDO and
1,4-BDO are non-natural metabolites, produced only with the
aid of novel, engineered metabolic pathways. Like 2,3-BDO,
1,4-BDO can be similarly converted to butadiene. More impor-
tantly, however, both 1,3-PDO and 1,4-BDO are directly useful
as biomonomers for the polyesters poly(propylene terephthalate)
(PPT) and poly(butylene terephthalate) (PBT). Both PPT and
PBT have the potential to steal market share from what is per-
haps the oldest polyester, polyethylene terephthalate (PET) (Haas
et al., 2005).
While microbial production of 1,3-PDO has been recently and
comprehensively reviewed (Nakamura and Whited, 2003; Sauer
et al., 2008; Saxena et al., 2009; Celinska, 2010), the engineer-
ing of E. coli to produce up to 18 g/L 1,4-BDO from glucose
(as well as other substrates) was only recently reported for the
first time (Yim et al., 2011). Bioproduction of 1,4-BDO was
accomplished through the development of two novel pathways
(Figure 7), the design of which was facilitated using the SimPheny
Biopathway Predictor; a design algorithm that considers chemical
structure to predict possible routes from central metabolite pre-
cursors to end-product targets (Smolke, 2009). It is also noted
that, as seen in Figure 7, both 1,4-BDO pathways include the
common intermediate 4-hydroxybutyrate (4HB), a hydroxyacid.
As described above, hydroxyacids are excellent precursors for
polyester production. Thus, by further leveraging this technology
an additional, non-natural hydroxyacid building block could also
be added to the list of potential polyester biomonomers. As their
flagship molecule, Genomatica (San Diego, CA) is now develop-
ing 1,4-BDO at the commercial scale. Moreover, NatureWorks
and BioAmber recently formed a joint venture (AmberWorks)
to explore the development of 100% renewable polyester co-
polymers of 1,4-BDO and succinic acid (PBS).
CONCLUSIONS
Whereas most monomer compounds and their respective poly-
mers are presently derived from non-renewable petroleum, by
application of metabolic engineering to create novel enzyme
FIGURE 7 | Pathway engineered by Yim et al. for the microbial production
of 1,4-butanediol (1,4-BDO) through the hydroxyacid intermediate
4-hydroxybutyrate (4HB). 1. 2-oxoglutarate decarboxylase; 2. succinyl-CoA
synthetase; 3. CoA-dependent succinate semialdehyde dehydrogenase;
4. 4-hydroxybutyrate dehydrogenase; 5. 4-hydroxybutyryl-CoA transferase;
6. 4-hydroxybutyryl-CoA reductase; 7. alcohol dehydrogenase.
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pathways this is beginning to change. The rapidly expanding
number and diversity of biomonomers will continue to support
the development of new markets for “green” and sustainable
bioplastics with properties identical to their petroleum-derived
counterparts. With the aid of continued research and develop-
ment, renewable biomonomers will ultimately help to reduce
global oil consumption while also promoting greater environ-
mental sustainability.
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